EA8184 (JIT – If a possible patient is identified, notify CRA asap as it will take time to open trial through NCORP)
Study Number: EA8184 (JIT – If a possible patient is identified, notify CRA asap as it will take time to open trial through NCORP)
This phase II trial studies how well green tea catechins work in preventing progression of prostate cancer from a low risk stage to higher risk stages in men who are on active surveillance. Green tea catechins may stabilize prostate cancer and lower the chance of prostate growing.
- Missouri Baptist Medical Center
- Mckenzie King 314-996-5865
View More Information - This link will take you to clinicaltrials.gov for specific study information including eligibility criteria. A full list of participating institutions can also be found on this page.